Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RBP4 | P02753 | 16/20 | 0.54 |
| ▸ | TTR | P02766 | 11/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27680981 | 0.92 | KDM4E (0.60) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL13494044 | 0.82 | KDM4E (0.81) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL31539367 | 0.81 | KDM4E (0.47) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL27681034 | 0.80 | RBP4 (0.56) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL1179851 | 0.79 | RBP4 (0.59) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL30637298 | 0.78 | RBP4 (0.64) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL12552670 | 0.78 | RBP4 (0.55) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL27681017 | 0.78 | RBP4 (0.61) | RBP4TTRKDM4EHSD17B10MEN1 | |
| SCHEMBL5216228 | 0.78 | RBP4 (0.57) | RBP4TTRKDM4EHSD17B10USP2 | |
| SCHEMBL6396185 | 0.77 | RBP4 (0.69) | RBP4TTRKDM4EHSD17B10USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101023063-A | Azine-carboxamides as anti-cancer agents | ASTRAZENECA AB (SE) | 2007-08-22 | — | — | CN | disclosed |